Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded ― particularly, the risk of infection to ...
Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...
INDIANAPOLIS, (WISH) – The holidays are about spreading joy, but it’s also a time when celebrating with friends and family can get us sick. On Tuesday, Dr. Mary Rodgers, a Ph.D. who is an Abbott ...
A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening outlook. Click for this EXAS update.
InvestorsHub on MSN
Abbott shares slide after Q4 revenue comes in short, outlook disappoints
Abbott Laboratories (NYSE:ABT) shares fell about 4.8% after the company reported fourth-quarter results that met earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback